Geron | GERN - Frais De Vente Et D'Administration





Frais De Vente Et D'Administration Changement Date
Amgen USD 1.58B 354M 2026-03
Bio Techne USD 109.34M 4.35M 2026-03
Cassava Sciences USD 6.66M 1.24M 2025-12
Cytokinetics USD 104.9M 13.17M 2026-03
Esperion Therapeutics USD 39.42M 456K 2025-12
Exelixis USD 139.6M 16.58M 2026-03
Genmab DKK 208M 60M 2025-12
Geron USD 35.42M 6.24M 2026-03
Gilead Sciences USD 1.45B 326M 2026-03
Incyte USD 328.1M 62.31M 2026-03
MacroGenics USD 7.94M 1.96M 2025-12
Novartis USD 3.14B 296M 2026-03
Novavax USD 25.53M 1.34M 2025-12